MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by VOLPI, M.
Right arrow Articles by FEINSTEIN, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by VOLPI, M.
Right arrow Articles by FEINSTEIN, M. B.

Molecular Pharmacology, Vol 20, 363-370, Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics

Antagonism of Calmodulin by Local Anesthetics

Inhibition of Calmodulin-Stimulated Calcium Transport of Erythrocyte Inside-Out Membrane Vesicles

M. VOLPI 1, R. I. SHA’AFI 1, and M. B. FEINSTEIN 1

1 Department of Physiology and Department of Pharmacology, University of Connecticut Health Center, Farmington, Connecticut 06032

Transport of calcium across the erythrocyte membrane is regulated by a Ca2+-activated, Mg2+-dependent ATPase which is stimulated by calmodulin. The regulation of Ca2+ transport by calmodulin was studied in inside-out membrane vesicles (IO vesicles) prepared from erythrocytes treated with protease inhibitors and lysed in media containing ethylene glycol bis(beta-aminoethyl ether)-N,N,N’,N’-tetraacetic acid and EDTA. Ca2+ uptake by IO vesicles was absolutely dependent on ATP, and the basal rate of uptake was 14.3 ± 1.1 nmoles/mg of IO vesicle protein per minute at a saturating concentration of free Ca2+ in the medium. Calmodulin stimulated Ca2+ uptake by an average of 3.5-fold to a Vmax of 49.4 ± 3.9 nmoles/mg of IO vesicle protein per minute. The K0.5 for calmodulin was 4.9 ± 0.9 nM and the maximal initial rate of Ca2+ uptake was attained at about 64 nM calmodulin. In a medium containing 80 mM Na+, calmodulin reduced the K0.5 for Ca2+ from 8.9 ± 1.8 µM (n = 3) to 5.0 ± 0.3 µM, but in a medium in which all Na+ was replaced by K+, calmodulin decreased K0.5 Ca2+ to 1.4 µM free Ca2+. Certain local anesthetics and drugs with local anesthetic-like properties (e.g., dibucaine, tetracaine, QX572, proadifen, mepacrine, quinine, propranolol, phenacaine, monocaine, and procaine), as well as trifluoperazine, inhibited calmodulin-stimulated Ca2+ uptake into IO vesicles. Calmodulin-stimulated (Ca2+ + Mg2+)-ATPase activity was inhibited to a degree equivalent to the effect on calcium uptake. Basal Ca2+ uptake (minus calmodulin) was only weakly inhibited; e.g., dibucaine at 1.0 mM inhibited stimulation by calmodulin 96.9%, but reduced basal Ca2+ uptake by only 11.4%. The local anesthetics increased the K0.5 for calmodulin and reduced Vmax for Ca2+ uptake. The reduction of Vmax by local anesthetics was dose-dependent: e.g., 35% reduction at 0.25 mM dibucaine and 65% reduction at 0.5 mM dibucaine. Vmax could not be restored to control levels by the addition of an excess of either calmodulin or Ca2+. The antagonism of calmodulin by local anesthetics appeared to have elements of both competitive and noncompetitive inhibition. The antagonism versus Ca2+ was uncompetitive. These results are in agreement with our previous findings that certain local anesthetics are antagonists of calmodulin-stimulated (Ca2+ + Mg2+)-ATPase and calmodulin-stimulated cyclic nucleotide phosphodiesterase. It is suggested that certain of the well-known inhibitory effects of local anesthetics on Ca2+-dependent cellular functions may be due to inhibition of the role played by calmodulin in facilitating these Ca2+-dependent processes.

Submitted on November 17, 1980
Accepted on April 7, 1981







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics